Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Gastrointestinal bleeding in adults".)
●(See "Society guideline links: Gastrointestinal bleeding in children".)
●(See "Society guideline links: Pediatric liver disease".)
●(See "Society guideline links: Cystic fibrosis".)
International
●North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension (2022)
●Baveno VII Consensus Workshop: Renewing consensus in portal hypertension (2021)
●Baveno VI Pediatric Satellite Symposium: Summary on primary prophylaxis of variceal bleeding in children and the role of MesoRx bypass (2016)
●Portal hypertension in children – Expert pediatric opinion on the report of the Baveno V Consensus Workshop on methodology of diagnosis and therapy in portal hypertension (2012)
United States
●American Association for the Study of Liver Diseases (AASLD): Practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis (2023)
●Cystic Fibrosis Foundation (CFF): Consensus recommendations on cystic fibrosis screening, evaluation, and management of hepatobiliary disease (2023)
●AASLD: Practice guidance for the diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome (2021)
●American College of Gastroenterology (ACG): Clinical guideline – Disorders of the hepatic and mesenteric circulation (2020)
●American College of Radiology (ACR): ACR Appropriateness Criteria on radiologic management of portal hypertension (2020)
●Society of Interventional Radiology (SIR): Quality improvement guidelines for transjugular intrahepatic portosystemic shunts (2016)
●AASLD: Practice guideline update on the role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension – Update 2009 (published 2010)
Europe
●European Society of Gastrointestinal Endoscopy (ESGE): Guideline on endoscopic diagnosis and management of esophagogastric variceal hemorrhage (2022)
●European Association for the Study of the Liver (EASL): Clinical practice guidelines for the management of patients with decompensated cirrhosis (2018)
●EASL: Clinical practice guidelines on vascular diseases of the liver (2015)
●Cardiovascular and Interventional Radiological Society of Europe (CIRSE): Quality improvement guidelines for transjugular intrahepatic portosystemic shunt (TIPS) (2012)
●EASL: Clinical practice guidelines for the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis (2010)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on cirrhosis in over 16s – Assessment and management (2016, updated 2023)
●NICE: Interventional procedures guidance on tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis (2022)
●NICE: Medical technologies guidance on pleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites (2012, updated 2022)
●British Society of Gastroenterology (BSG): Guidelines on the management of ascites in cirrhosis (2020)
●BSG: Guidelines on transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension (2020)
●NICE: Interventional procedures guidance on subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis (2018)
India
●Asian Pacific Association for the Study of the Liver (APASL): Recommendations for diagnosis and treatment of noncirrhotic portal fibrosis/idiopathic portal hypertension (2007)
Australia–New Zealand
●Asian Pacific Association for the Study of the Liver (APASL): Recommendations for diagnosis and treatment of noncirrhotic portal fibrosis/idiopathic portal hypertension (2007)
Japan
●Asian Pacific Association for the Study of the Liver (APASL): Recommendations for diagnosis and treatment of noncirrhotic portal fibrosis/idiopathic portal hypertension (2007)
